Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

MA Nauck; G Meininger; D Sheng; L Terranella; PP Stein; Jorma Lahtela

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

MA Nauck, G Meininger, D Sheng, L Terranella, PP Stein, Jorma Lahtela

Department of Internal medicine

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Pages (from-to)	194-205
Journal	Diabetes Obes Metab
Volume	9
Issue number	2
Publication status	Published - 2007
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{99e152a79814412dab426990c33e54a7,

title = "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial",

author = "MA Nauck and G Meininger and D Sheng and L Terranella and PP Stein and Jorma Lahtela",

year = "2007",

language = "English",

volume = "9",

pages = "194--205",

number = "2",

}

Nauck, MA, Meininger, G, Sheng, D, Terranella, L, Stein, PP & Lahtela, J 2007, 'Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial', Diabetes Obes Metab, vol. 9, no. 2, pp. 194-205.

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. / Nauck, MA; Meininger, G; Sheng, D et al.

In: Diabetes Obes Metab, Vol. 9, No. 2, 2007, p. 194-205.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

AU - Nauck, MA

AU - Meininger, G

AU - Sheng, D

AU - Terranella, L

AU - Stein, PP

AU - Lahtela, Jorma

PY - 2007

Y1 - 2007

M3 - Article

VL - 9

SP - 194

EP - 205

IS - 2

ER -